A drug designed by generative artificial intelligence has made history by reaching Phase 2 human trials for the first time.
their new INS018-055 drug was designed with such time-saving assistance from generative A.I.:
In the future, AI pharmaceuticals represent vast market space. According to BCC Research, the market size for AI-driven drug development is projected to reach $3.117 billion by 2024, with a compound annual growth rate of 40.7 percent. “Our company, and it’s a big, bold claim, can double the productivity of pretty much every big pharma company,” he said, adding that A.I. is also helpful for finding ideal patients to undergo clinical trials.
The Harvard Law paper found third-party investment in A.I. drug research surging to over $5.2 billion in 2021, with over a dozen top firms raising hundreds of millions in funding apiece – but, as thepointed out, the lack of successful drug product development over the past two years is curbing the enthusiasm of investors.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
King Charles Unveils Jony Ive-Designed Seal for ‘Astra Carta’ Space Sustainability InitiativeAstra Carta emphasizes sustainable practices for private space companies, and features a logo designed by Apple's former chief design officer Jony Ive.
Read more »
Disabled veteran gifted custom-designed home in Canyon LakeBrian Boone lost the lower part of his leg while on deployment to Afghanistan. In this edition of FOX 7 Care Force, we learn about his new custom-designed home, gifted by Homes For Our Troops, that has over 40 special adaptations for Boone's disability.
Read more »
Single Molecule Infrared Spectroscopy in the Gas Phase - NatureNature research paper: Single Molecule Infrared Spectroscopy in the Gas Phase
Read more »
A New Intelligence Report Suggests That the Lab-Leak Wars Will Never EndGiven a 90-day deadline to share what they know about COVID’s origins, America’s divided intelligence agencies produced a slim report that leaves both major hypotheses on the table—and raises as many questions as it answers. KatherineEban reports:
Read more »
Phase separation of FSP1 promotes ferroptosis - NatureAn inhibitor of the ferroptosis-suppressing FSP1 induces phase separation of FSP1, thereby impairing its function and reducing tumour growth.
Read more »